| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f36a99247c7f61a3fdfa1f28f7a43eb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41106ec394961cbab4b5e362226435fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6309fcb38cd943c73c90103766e233c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_755f0e063405a160b3444126780baba9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc097af5598c1c25e574ebb6e4cb0f4b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C31-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-12 |
| filingDate |
2017-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45a99582dbb8f02ce723e874ef2ed0d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d3a4d400a7b54c6a663933b0a538aae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40bffb8ef72317f57665055c078c3587
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19fcf0834b190710ee86de969e13bc8b |
| publicationDate |
2020-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10759772-B2 |
| titleOfInvention |
Process for the preparation of DL-proline co-crystal of Dapagliflozin |
| abstract |
The present invention relates to a process For the preparation of Dapagliflozin DL-Proline co-crystal and its use in the preparation/purification of Dapagliflozin. The invention also provides a process for the preparation of Dapagliflozin (R,S)-1.2-propanediol monohydrate. |
| priorityDate |
2016-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |